Literature DB >> 12094473

Immunophenotypic analysis of acute lymphocytic leukemia.

Roger S Riley1, Davis Massey, Colleen Jackson-Cook, Michael Idowu, Gina Romagnoli.   

Abstract

Acute lymphoblastic leukemia (ALL) is one of the most common hematologic malignancies. Flow cytometry is an integral part of ALL diagnosis and also provides significant patient prognostic information. This article is a practical review of the basic principles of the flow cytometric evaluation of acute leukemias, the interpretation of flow cytometric data, and the management of practical problems such as aberrant antigen, hematogones, bone marrow regeneration, and minimal residual disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094473     DOI: 10.1016/s0889-8588(02)00004-7

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  3 in total

1.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Canine acute leukaemia: 50 cases (1989-2014).

Authors:  A L Bennett; L E Williams; M W Ferguson; M L Hauck; S E Suter; C B Lanier; P R Hess
Journal:  Vet Comp Oncol       Date:  2016-07-12       Impact factor: 2.613

3.  T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).

Authors:  David I Marks; Elisabeth M Paietta; Anthony V Moorman; Susan M Richards; Georgina Buck; Gordon DeWald; Adolfo Ferrando; Adele K Fielding; Anthony H Goldstone; Rhett P Ketterling; Mark R Litzow; Selina M Luger; Andrew K McMillan; Marc R Mansour; Jacob M Rowe; Martin S Tallman; Hillard M Lazarus
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.